✓ Credit card payment restored — secure checkout via Privacy Shield
Morgan Ellis, pharmacy researcher and medical reviewer at MedsBase

Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

Key Takeaways

  • Migraine treatment splits into two pillars: acute attack abortives (taken at first symptoms) and preventive medications (taken daily to reduce attack frequency).
  • For acute attacks, a triptan like Suminat (sumatriptan) or Rizact (rizatriptan) is first-line for moderate-to-severe attacks — take at first sign of pain, not at the aura.
  • For nausea-dominant attacks or when triptan tablets are vomited up, Zolmist Nasal Spray (zolmitriptan) bypasses the gut.
  • For prevention (≥4 attacks/month or attacks that disable activity), beta-blocker Inderal LA (propranolol), anti-epileptic Topicon (topiramate), or CCB Sibelium (flunarizine) are the three best-evidence first-line preventives.
  • Avoid taking acute medication >10 days/month — triptans, NSAIDs, and combo analgesics can convert episodic migraine into chronic medication-overuse headache.

Best Migraine Medications in 2026: 10 Evidence-Backed Picks for Acute Attacks and Prevention

Migraine affects 12–15% of adults worldwide and is the second-leading cause of years-lived-with-disability. The treatment landscape has matured into two clear tracks — aborting an attack that’s already started, and preventing future attacks — with different drug classes for each. This guide ranks the 10 migraine medications most worth knowing about in 2026, splitting them into acute and preventive picks, and showing where each fits.

The acute side is dominated by triptans, which selectively constrict cranial vasodilatation and inhibit trigeminovascular pain transmission — vastly more migraine-specific than NSAIDs or combo analgesics. The preventive side is more eclectic: beta-blockers, anti-epileptics, CCBs, antidepressants, and (more recently) CGRP-pathway monoclonals all work through different mechanisms and reach roughly the same 50% reduction in attack frequency in trials.

Acute vs preventive treatment

Acute (abortive) treatment is taken at the first sign of an attack to stop it before peak pain. Triptans (sumatriptan, rizatriptan, zolmitriptan) are the migraine-specific class. NSAIDs (naproxen, ibuprofen) work for milder attacks. Combination triptan-NSAID (sumatriptan + naproxen, sold as Cotrip) outperforms either alone in trials. Anti-emetics (prochlorperazine, metoclopramide) treat the nausea component and modestly reduce headache pain.

Preventive treatment is taken daily, regardless of whether you have a headache that day, to reduce attack frequency by ~50% in responders. Indications: ≥4 attacks/month, severe attacks lasting >72 hours, attacks resistant to or contraindicated for acute therapy, or significant disability from attacks even at lower frequency. The three best-evidence first-line classes are beta-blockers (propranolol — Inderal LA), anti-epileptics (topiramate — Topicon, sodium valproate — Encorate), and calcium channel blockers (flunarizine — Sibelium). All require 8–12 weeks of dosing to assess response.

The 10 picks (ranked)

1. Suminat (sumatriptan 50 / 100 mg) — the original triptan, still the most-prescribed acute migraine drug

Sumatriptan is the original triptan (in market since 1991) and remains first-line for moderate-to-severe acute migraine attacks. The standard adult dose is 50 mg at first sign of pain, repeated at 2 hours if needed (max 200 mg/day). 100 mg is the right dose for attacks that have historically been severe. Take at the first sign of pain, NOT at the aura — triptans work better the earlier they’re given but the aura phase has minimal vasoconstriction-target activity. Contraindicated in coronary artery disease, uncontrolled hypertension, and within 24 hours of an ergot. Buy Suminat.

2. Rizact (rizatriptan 5 / 10 mg) — the fastest-onset oral triptan

Rizatriptan reaches peak plasma levels in ~1 hour vs sumatriptan’s 1.5–2 hours, and the orodispersible (MLT) formulation can be taken without water — useful for the patient who’s already nauseated. 10 mg is the standard dose; reduce to 5 mg if also taking propranolol (propranolol nearly doubles rizatriptan plasma levels). Higher 2-hour pain-free response rate than sumatriptan in head-to-head trials. Buy Rizact.

3. Zolmist Nasal Spray (zolmitriptan 5 mg intranasal) — the right tool when nausea or vomiting is dominant

Intranasal zolmitriptan bypasses the gut entirely — right choice when the migraine starts with severe nausea, when oral tablets get vomited back up, or when onset speed matters most. Onset is faster than oral triptan (15–30 minutes vs 1–2 hours). One spray (5 mg) into a single nostril; can repeat at 2 hours. Common side effect is the bitter aftertaste from drainage down the back of the nose — sip water afterwards. Buy Zolmist Nasal Spray.

4. Cotrip (sumatriptan 85 mg + naproxen sodium 500 mg) — the combination that outperforms either alone

The fixed-dose triptan-NSAID combo has the strongest evidence of any acute migraine therapy — in head-to-head trials, sumatriptan-naproxen 85/500 gives ~65% 2-hour pain-free response vs ~50% for sumatriptan alone or naproxen alone. The two drugs work through different mechanisms (5-HT receptor agonism + COX inhibition) and the combination has lower 24-hour recurrence rates — the “migraine comes back at hour 8” problem that’s common with triptan monotherapy. One tablet at first sign of pain; repeat at 2 hours if needed. Buy Cotrip.

5. Naprosyn (naproxen 250 / 500 mg) — the NSAID first-line for milder attacks or triptan-contraindicated patients

Naproxen 500 mg at attack onset, repeat 250–500 mg at 8–12 hours if needed, is first-line for mild-to-moderate migraine attacks and the right choice when triptans are contraindicated (coronary artery disease, uncontrolled hypertension, hemiplegic migraine). Naproxen has the longest half-life of common NSAIDs (12–15 hours), so it covers the recurrence risk window better than ibuprofen. Avoid in active peptic ulcer disease, severe heart failure, or stage 3+ CKD. Take with food. Buy Naprosyn.

6. Primox (prochlorperazine 5 mg) — the anti-emetic that also treats migraine pain

Prochlorperazine is a phenothiazine D2-receptor antagonist used for nausea and vomiting in acute migraine. The dose is 5–10 mg orally at attack onset; the IM or IV form (in hospital settings) provides reliable acute relief that often resolves the entire migraine attack, not just the nausea. Modest sedation is common — useful for the patient who needs to sleep through an attack but inappropriate for daytime work. Avoid in Parkinson’s disease and at higher doses can cause acute dystonic reactions in younger patients. Buy Primox.

7. Inderal LA (propranolol LA 80 / 160 mg) — the first-line preventive for ≥4 attacks/month

Propranolol is the most-evidence first-line migraine preventive — it cuts attack frequency by ~50% in 2/3 of patients within 8–12 weeks. The long-acting (LA) formulation allows once-daily dosing, starting at 80 mg and titrating up to 160–240 mg as tolerated. Best preventive choice for patients who also have hypertension, anxiety, or essential tremor (kills 3 birds with one stone). Avoid in asthma, COPD, severe peripheral vascular disease, advanced AV block, or significant depression. Buy Inderal LA.

8. Sibelium (flunarizine 5 / 10 mg) — the calcium-channel-blocker preventive with the cleanest tolerability

Flunarizine is a selective T-type CCB used as a migraine preventive in much of Europe, Asia, and Latin America (less common in the US). 5–10 mg at bedtime gives a comparable ~50% attack reduction to propranolol or topiramate, with a different side-effect profile (drowsiness and modest weight gain are most common). Best preventive choice for patients with comorbid vertigo, paediatric migraine, or in patients where beta-blocker / anti-epileptic side effects haven’t been tolerated. Buy Sibelium.

9. Topicon (topiramate 25 / 50 / 100 mg) — the anti-epileptic preventive with the strongest weight-neutral / weight-loss profile

Topiramate is FDA-approved for migraine prevention; ~50% attack-frequency reduction at 100–200 mg/day. The standard ramp is 25 mg at bedtime for 1 week, then increase by 25 mg/week to a target of 100 mg/day in two divided doses. Topiramate is the preventive of choice for patients who would benefit from the modest weight loss it produces (vs propranolol or flunarizine which can cause weight gain) and for patients with comorbid epilepsy. Side effects to watch: paraesthesias (often dose-limiting), cognitive slowing (“Dopamax”), kidney stones, narrow-angle glaucoma. Contraindicated in pregnancy planning — topiramate is teratogenic. Buy Topicon.

10. Encorate Chrono (sodium valproate ER) — the anti-epileptic preventive with the most data on chronic migraine

Sodium valproate at 500–1500 mg/day is FDA-approved for migraine prevention with ~50% attack-frequency reduction. The Chrono (extended-release) formulation allows once-daily dosing and reduces the GI side effects of immediate-release valproate. Best preventive choice for chronic migraine (≥15 headache days/month) and for patients with comorbid bipolar disorder. Two non-negotiable safeguards: (1) absolute contraindication in pregnancy planning — valproate is among the most teratogenic anti-epileptics, with high rates of neural tube defects and IQ impairment in exposed children, and (2) baseline + periodic LFTs — valproate can cause idiosyncratic hepatic failure. Buy Encorate Chrono.

Comparison table

BrandMoleculeTypeOnset / Time-to-effectBest for
SuminatSumatriptan 50/100 mgAcute (triptan)1–2 hModerate-to-severe attacks, default first triptan
RizactRizatriptan 5/10 mgAcute (triptan)~1 hFaster onset, ODT available
Zolmist Nasal SprayZolmitriptan 5 mg INHAcute (triptan)15–30 minNausea/vomiting dominant, fastest oral-pathway alt
CotripSumatriptan 85 + naproxen 500Acute (combo)1–2 hHighest 2-h pain-free rate, lower recurrence
NaprosynNaproxen 250/500 mgAcute (NSAID)1–2 hMild-to-moderate, triptan-contraindicated
PrimoxProchlorperazine 5 mgAcute (anti-emetic)30–60 minNausea + sleep through attack
Inderal LAPropranolol LA 80–160 mgPreventive (BB)8–12 weeksFirst-line preventive, +HTN/anxiety/tremor
SibeliumFlunarizine 5–10 mgPreventive (CCB)8–12 weeks+vertigo, paeds, BB-intolerant
TopiconTopiramate 25–200 mgPreventive (AED)8–12 weeksWants weight loss, +epilepsy
Encorate ChronoSodium valproate ERPreventive (AED)8–12 weeksChronic migraine, +bipolar; no pregnancy

Decision shortcut

  • Mild attack, no nausea: Naprosyn 500 mg at first sign of pain.
  • Moderate-to-severe attack, no contraindications: Suminat 50–100 mg or Rizact 10 mg at first sign of pain.
  • Attack with significant nausea or vomiting: Zolmist Nasal Spray 5 mg, OR Primox 10 mg + triptan.
  • Severe attacks where triptan alone keeps coming back: Cotrip (sumatriptan + naproxen) for higher 24-h sustained response.
  • Triptan-contraindicated (CAD, uncontrolled HTN, hemiplegic migraine): Naprosyn 500 mg + Primox 10 mg.
  • Preventive: ≥4 attacks/month + comorbid HTN or anxiety: Inderal LA 80 mg titrated to 160–240 mg.
  • Preventive: wants weight loss / has epilepsy: Topicon titrated to 100 mg/day.
  • Preventive: chronic migraine (≥15 headache days/mo): Encorate Chrono 500–1500 mg/day (NOT in patients of childbearing potential).
  • Preventive: BB / AED not tolerated, comorbid vertigo, paediatric: Sibelium 5–10 mg at bedtime.

Safety, contraindications, and the medication-overuse trap

Triptan contraindications: known coronary artery disease, prior myocardial infarction, uncontrolled hypertension, peripheral vascular disease, basilar or hemiplegic migraine, and within 24 hours of an ergot derivative. Triptans cause modest cranial vasoconstriction; the cardiovascular safety signal is real in patients with established CAD.

Triptan + SSRI / SNRI — the FDA serotonin-syndrome warning is well-known but the actual clinical risk is very low for combinations of a triptan + an antidepressant at standard doses. Patients can use both with awareness; reserve the warning for high-dose combinations or polypharmacy with multiple serotonergic drugs.

Medication-overuse headache (MOH) is the most important pitfall in migraine self-management. Taking acute medication on >10 days/month for >3 months can convert episodic migraine into chronic daily headache that feels like worse migraines but won’t respond to acute therapy. The triggers for MOH:

  • Triptans, ergots, opioids, butalbital combinations — on >10 days/month
  • Simple analgesics (paracetamol, NSAIDs, aspirin) — on >15 days/month
  • Combination analgesics (paracetamol+caffeine+codeine) — on >10 days/month

If you’re using acute migraine therapy more often than these thresholds, the answer is to start a preventive medication, not to keep escalating the acute. Detoxifying from the overused drug usually requires a short course of bridging therapy (corticosteroid taper, naproxen scheduled BID for 1–2 weeks).

Pregnancy considerations: sumatriptan is the most-studied triptan in pregnancy and considered relatively safe; rizatriptan and zolmitriptan have less data. Naproxen is contraindicated in T3 (premature ductal closure). Topiramate and valproate are absolute contraindications in pregnancy planning — both are highly teratogenic. Propranolol is safe; flunarizine has limited data; CGRP-pathway monoclonals (not on this list) are also avoided in pregnancy.

Non-drug measures with real evidence

  • Sleep hygiene — consistent sleep / wake times reduce attack frequency more than almost any other behavioural intervention.
  • Hydration and meal regularity — skipped meals and dehydration are top-3 triggers in headache diary studies.
  • Caffeine consistency — the trigger is variability (under or over your usual baseline), not caffeine itself. Don’t skip the morning coffee on weekends.
  • Aerobic exercise — 30 min × 3/week of moderate aerobic activity reduces frequency by ~30% in 12-week trials, comparable to topiramate but without the side effects.
  • Magnesium 400 mg/day — modest preventive benefit, especially in menstrual migraine. Cheap, well-tolerated.
  • Riboflavin 400 mg/day — ~50% reduction in attack frequency in some studies; takes 8–12 weeks to see effect; harmless.
  • CoQ10 100 mg three times daily — some evidence for preventive benefit, especially in adolescents.
  • Acupuncture — comparable to topiramate in some head-to-head trials for prevention; reasonable for patients who prefer non-pharmacological options.

Frequently Asked Questions

When should I take an acute migraine drug — at the aura or at first pain?

At first sign of pain, not at the aura. Triptans bind 5-HT receptors that are activated by the trigeminovascular pain transmission — this happens during the headache phase, not the aura phase. Taking sumatriptan during a 30-minute aura before pain starts will mostly waste the dose; the right time is the moment you can confidently identify the start of head pain. NSAIDs and combination triptan-NSAID can be taken at the aura (NSAID component does work in the prodromal phase) for some patients.

How is rizatriptan different from sumatriptan?

Faster onset (~1 hour vs 1.5–2 hours), higher 2-hour pain-free response rate in head-to-head trials, and orodispersible (MLT) form available without water. Rizatriptan is the better acute pick for patients who’ve found sumatriptan too slow or who can’t swallow tablets when nauseated. The dose interaction with propranolol is the main caveat — reduce rizatriptan to 5 mg (not 10 mg) if taking propranolol.

How long do I have to wait to know if a preventive is working?

8–12 weeks at the target dose. Don’t judge a preventive in the first 4 weeks — partial responses build over time. The standard endpoint is ≥50% reduction in monthly attack frequency. If you’re not at ≥50% reduction at week 12 of an adequate dose, the preventive isn’t working for you and it’s reasonable to switch.

Can I take a triptan and an NSAID together?

Yes — the combination is more effective than either alone (Cotrip is the fixed-dose product). The two work through different mechanisms and have lower 24-hour recurrence rates than triptan alone. The only real interaction caveat is that NSAIDs increase the risk of GI bleeding and serotonin-related cardiovascular effects modestly when combined with a triptan, but at standard acute-migraine doses the combination is well-studied and safe.

What is medication-overuse headache and how do I avoid it?

MOH is chronic daily headache caused by frequent acute migraine therapy. The triggers are triptans / ergots / opioids / butalbital on >10 days/month, simple analgesics on >15 days/month, or combination analgesics on >10 days/month. Avoid by tracking days-per-month of acute medication use, and starting a preventive whenever you cross or approach the threshold. The treatment is to stop the overused drug (sometimes with a bridging steroid taper) and add a preventive.

Is propranolol safe in asthma?

No. Propranolol is non-selective and blocks bronchial β2-receptors; bronchospasm in asthma can be life-threatening. Cardioselective beta-blockers (metoprolol, bisoprolol) have less β2 activity but are still not ideal in poorly-controlled asthma. For asthmatic patients needing preventive, choose topiramate (Topicon) or flunarizine (Sibelium) instead.

Why is valproate contraindicated in pregnancy planning?

Sodium valproate (Encorate Chrono) is among the most teratogenic anti-epileptics known — first-trimester exposure carries a ~10% absolute risk of major congenital malformations (especially neural tube defects) and a 30–40% risk of significant neurodevelopmental impairment in exposed children. Even women not currently planning pregnancy should generally avoid valproate unless on highly effective contraception, because half of pregnancies are unplanned. Topicon (topiramate) is also teratogenic but somewhat less so — still avoid in pregnancy planning.

How do CGRP monoclonals fit in?

CGRP-pathway monoclonals (erenumab, fremanezumab, galcanezumab, eptinezumab) are subcutaneous monthly or quarterly injections that target the calcitonin gene-related peptide pathway central to migraine pathogenesis. They’re very well-tolerated and reduce attack frequency by 50% in ~50% of treatment-resistant patients. They’re second-line preventives in most national guidelines — tried after at least 2 oral preventives have failed. Not in this catalogue today; ask your neurologist about access pathways if oral preventives haven’t worked.

Bottom line

For acute migraine, the right pick depends on attack severity and the dominant symptom: Naprosyn for mild attacks, Suminat or Rizact for moderate-to-severe, Cotrip for the highest sustained response, Zolmist Nasal Spray when nausea or vomiting dominates, and Primox as anti-emetic adjunct.

For prevention, three first-line classes match each other for efficacy; the choice is driven by comorbidity and side-effect tolerance: Inderal LA when also treating hypertension, anxiety, or essential tremor; Topicon when weight loss is wanted or comorbid epilepsy; Encorate Chrono for chronic migraine and bipolar overlap (NOT in patients of childbearing potential); Sibelium as the cleanest-tolerated CCB option.

The most important practical point: track days-per-month of acute medication use and start a preventive whenever acute use exceeds the medication-overuse-headache thresholds. Migraine is one of the conditions where the right preventive can transform daily life; it’s worth the 12-week trial.

Choosing between OTC pain relievers? See our detailed Aleve vs Ibuprofen comparison — naproxen vs ibuprofen for pain, arthritis, and fever.

Sophie Chen

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.

Leave a Reply

Your email address will not be published. Required fields are marked *